Cancidas and endocarditis Patient Reports February 10, 2012

Cancidas Side Effects Report #4898163-7
Cancidas side effect was reported by a Physician from UNITED STATES on Jan 10, 2006. Male patient, 32 years of age, was diagnosed with zygomycosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: aplasia pure red cell, disease progression, endocarditis , septic embolus. Cancidas dosage: unknown. During the same period patient was treated with FLUCONAZOLE, AMPHOTERICIN B, POSACONAZOLE. Patient died.

Cancidas Side Effects Report #4682592-0
Cancidas side effect was reported by a Physician from on May 24, 2005. Female patient, 70 years of age, was diagnosed with fungaemia, systemic candida, thrombophlebitis, enteral nutrition and was treated with Cancidas. After drug was administered, patient experienced the following side effects: atrial thrombosis, endocarditis . Cancidas dosage: unknown. During the same period patient was treated with FLUCONAZOLE, VORICONAZOLE. Patient was hospitalized. Patient recovered.

Cancidas Side Effects Report #6086521-7
Cancidas side effect was reported by a Consumer or non-health professional from SPAIN on Jan 30, 2009. Male patient, 70 years of age, was diagnosed with endocarditis , systemic candida, staphylococcal infection  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: anuria, cellulitis , clostridium difficile colitis, continuous haemodiafiltration, endocarditis , multi-organ failure, pneumonia , respiratory disorder, skin papilloma. Cancidas dosage: 70 MG/1X IV; 50 MG/DAILY IV. During the same period patient was treated with INFUSION, FLUCONAZOLE. Patient died.

Cancidas Side Effects Report #5785337-6
Cancidas side effect was reported by a Physician from FRANCE on June 18, 2008. Female patient, 49 years of age, was diagnosed with endocarditis  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: endocarditis , treatment failure. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE. Patient died.


Cancidas Side Effects Report #5830332-1
Cancidas side effect was reported by a Physician from FRANCE on June 18, 2008. Female patient, 49 years of age, was diagnosed with endocarditis  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: endocarditis , treatment failure. Cancidas dosage: unknown. During the same period patient was treated with VORICONAZOLE. Patient died.

Cancidas Side Effects Report #6085470-8
Cancidas side effect was reported by a Physician from SPAIN on Feb 10, 2009. Male patient, 70 years of age, was diagnosed with candidiasis, endocarditis , staphylococcal infection  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: anuria, cellulitis , clostridium difficile colitis, continuous haemodiafiltration, endocarditis , multi-organ failure, pneumonia , respiratory disorder, skin papilloma. Cancidas dosage: 70 MG 1X, IV; 50 MG DAILY; IV. During the same period patient was treated with RIFAMPICIN, FLUCONAZOLE. Patient died.

Cancidas Side Effects Report #5611717-5
Cancidas side effect was reported by a Health Professional from GREECE on Jan 24, 2008. Female patient, weighting 2.20 lb, was diagnosed with candidiasis, sepsis  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: endocarditis , mycetoma mycotic. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B AND CHOLESTEROL AND DISTEAROYLPHOSPHATIDYLGLYCEROL AND, AMPICILLIN, GENTAMICIN, MEROPENEM, TEICOPLANIN. Patient was hospitalized. Patient recovered.

Cancidas Side Effects Report #5611720-5
Cancidas side effect was reported by a Health Professional from GREECE on Jan 24, 2008. Male patient, weighting 2.20 lb, was diagnosed with candidiasis, staphylococcal infection  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: endocarditis , mycetoma mycotic. Cancidas dosage: unknown. During the same period patient was treated with AMPHOTERICIN B AND CHOLESTEROL AND DISTEAROYLPHOSPHATIDYLGLYCEROL AND, AMPICILLIN, GENTAMICIN, MEROPENEM, TEICOPLANIN. Patient was hospitalized. Patient recovered.

Cancidas Side Effects Report #5030637-0
Cancidas side effect was reported by a Physician from GERMANY on June 08, 2006. Male patient, 70 years of age, was diagnosed with candida sepsis, endocarditis  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: candida sepsis, endocarditis . Cancidas dosage: unknown. Patient died.


Cancidas Side Effects Report #5040643-8
Cancidas side effect was reported by a Physician from GERMANY on June 08, 2006. Male patient, 70 years of age, was diagnosed with candida sepsis, endocarditis  and was treated with Cancidas. After drug was administered, patient experienced the following side effects: candida sepsis, endocarditis . Cancidas dosage: unknown. During the same period patient was treated with BELOC, LANICOR, HYDROCORTISONE, NOVALGIN, RANITIDINE HYDROCHLORIDE, VOLTAREN, REFOBACIN. Patient died on 09/08/2005.

Cancidas Side Effects Report #4746504-3
Cancidas side effect was reported by a Consumer or non-health professional from BELGIUM on July 28, 2005. Female patient, 46 years of age, was diagnosed with aspergillosis and was treated with Cancidas. After drug was administered, patient experienced the following side effects: cerebral aspergillosis, confusional state, depressed level of consciousness, encephalitis , encephalitis viral, endocarditis , enterococcal infection, hemiparesis, lung infiltration. Cancidas dosage: 50 MG/DAILY, IV. During the same period patient was treated with CYCLOSPORINE, MEROPENEM. Patient died.

Cancidas Side Effects Report #5448054-8
Cancidas side effect was reported by a Consumer or non-health professional from POLAND on Aug 31, 2007. Male patient, weighting 8.82 lb, was treated with Cancidas. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood urea increased, cardiac output, endocarditis , off label use, pneumonia , sepsis . Cancidas dosage: unknown. During the same period patient was treated with VANCOMYCIN, CILASTATIN AND IMIPENEM, AMPHOTERICIN B. Patient was hospitalized. Patient recovered.